• 제목/요약/키워드: recurrent disease

검색결과 669건 처리시간 0.024초

청피반성 혈관병증 치험 1례 (A Case of Treatment of Livedo Vasculopathy)

  • 한은정;김찬중;홍승욱;김윤범
    • 한방안이비인후피부과학회지
    • /
    • 제14권2호
    • /
    • pp.84-88
    • /
    • 2001
  • Livedo vasculopathy clinically shows purpuric papules and recurrent ulcers in the lower extremities, mainly on the ankles, leaving characteristic scars called atrophie blanche after the healing of the ulcers. In Korean literture, about 10 cases of this disease have been reported but nothing in korean oriental medicine. So, we report a case of livedo vasculopathy in a 46 year-old female patient treated by oriental medicine therapy.

  • PDF

Analysis of an Internet Community about Pneumothorax and the Importance of Accurate Information about the Disease

  • Kim, Bong Jun;Lee, Sungsoo
    • Journal of Chest Surgery
    • /
    • 제51권2호
    • /
    • pp.85-91
    • /
    • 2018
  • Background: The huge improvements in the speed of data transmission and the increasing amount of data available as the Internet has expanded have made it easy to obtain information about any disease. Since pneumothorax frequently occurs in young adolescents, patients often search the Internet for information on pneumothorax. Methods: This study analyzed an Internet community for exchanging information on pneumothorax, with an emphasis on the importance of accurate information and doctors' role in providing such information. Results: This study assessed 599,178 visitors to the Internet community from June 2008 to April 2017. There was an average of 190 visitors, 2.2 posts, and 4.5 replies per day. A total of 6,513 posts were made, and 63.3% of them included questions about the disease. The visitors mostly searched for terms such as 'pneumothorax,' 'recurrent pneumothorax,' 'pneumothorax operation,' and 'obtaining a medical certification of having been diagnosed with pneumothorax.' However, 22% of the pneumothorax-related posts by visitors contained inaccurate information. Conclusion: Internet communities can be an important source of information. However, incorrect information about a disease can be harmful for patients. We, as doctors, should try to provide more in-depth information about diseases to patients and to disseminate accurate information about diseases in Internet communities.

Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy

  • Kang, Jin-Han
    • Clinical and Experimental Pediatrics
    • /
    • 제57권4호
    • /
    • pp.164-170
    • /
    • 2014
  • Influenza causes acute respiratory infections and various complications. Children in the high-risk group have higher complication and hospitalization rates than high-risk elderly individuals. Influenza prevention in children is important, as they can be a source infection spread in their communities. Influenza vaccination is strongly recommended for high-risk children with chronic underlying circulatory and respiratory disease, immature infants, and children receiving long-term immunosuppressant treatment or aspirin. However, vaccination rates in these children are low because of concerns regarding the exacerbation of underlying diseases and vaccine efficacy. To address these concerns, many clinical studies on children with underlying respiratory diseases have been conducted since the 1970s. Most of these reported no differences in immunogenicity or adverse reactions between healthy children and those with underlying respiratory diseases and no adverse effects of the influenza vaccine on the disease course. Further to these studies, the inactivated split-virus influenza vaccine is recommended for children with underlying respiratory disease, in many countries. However, the live-attenuated influenza vaccine (LAIV) is not recommended for children younger than 5 years with asthma or recurrent wheezing. Influenza vaccination is contraindicated in patients with severe allergies to egg, chicken, or feathers, because egg-cultivated influenza vaccines may contain ovalbumin. There has been no recent report of serious adverse events after influenza vaccination in children with egg allergy. However, many experts recommend the trivalent influenza vaccine for patients with severe egg allergy, with close observation for 30 minutes after vaccination. LAIV is still not recommended for patients with asthma or egg allergy.

Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab

  • Jung, Hye-In;Kim, Hyun Jung;Kim, Ji-Min;Lee, Ju Yup;Park, Kyung Sik;Cho, Kwang Bum;Lee, Yoo Jin
    • Journal of Yeungnam Medical Science
    • /
    • 제38권1호
    • /
    • pp.70-73
    • /
    • 2021
  • Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.

베체트병의 동물모형에 대한 사심탕류 투여 효과에 관한 연구 (Experimental Studies on the Kinds of Sasim-tang In Behcet's Disease Symptoms in ICR Mice)

  • 이선구;안규석
    • 동의생리병리학회지
    • /
    • 제18권4호
    • /
    • pp.1061-1070
    • /
    • 2004
  • Chronic oral aphthae, recurrent ulcer and uveitis are the three main festations of Behcet's disease(BD). The aetiopathogenesis of Behcet's disease is still obscure, but herpes simplex virus is one of the possible casual factors. Gamchosasim-tang (Gancaoxiexin-tang), Banhasasim-tang(Banxiaxiexin-tang) and Saenggangsasim-tang( Shengjiangxiexin-tang) are traditional medication in Oriental medicine, that has been used to treat inflammatory disease. Especially, Gamchosasim-tang used to treat Behcet's disease like symptoms. ICR mice were used for this study. The earlobe of the mice were scratched with a needle, then inoculation with 1.0×10/sup 6/ plaque forming units/㎖ of HSV type I. Virus inoculation was performed twice with 10 day interval, followed by 16 weeks of observation. Using the HSV-induced Behcet's disease mouse model, kinds of Sasim-tang were administered variously before and after inoculation. In order to. classify the symptomatic mice as having Behcet's disease like symptoms. We followed the revised Japanese classification with minor modifications. Ulceration of the mice were monitored. In addition, spleen cytokine expression were measured by polymerase chain reaction, ELISA. HSV DNA was detected in HSV inoculation mice. HSV-induced mice treated with kinds of Sasim-tang showed improvement in symptom. In RT-PCR results, IFN-γ was expressed for all groups, IL-2 was expressed for the treated groups, and IL-10 was also expressed. IL-4 was expressed nothing. In ELISA, IL-2 was increased for GSST 2, BSST 2, GSST 2, GSST3 and INF-γ was increased for GSST 2, BSST 2, SSST 2, SSST 3. This model suggest the possible role of immune response to viral infection in the development and activation of Behcet's disease.

침윤성 자궁경부암 환자에서 SCC Antigen (TA-4) 측정의 유용성 (Vslue of Squamous Cell Carcinoma Associated Antigen fTA-41 in Patients Iurith Invasive Carcinoma of the Uterine Cervix)

  • 조문준;김재성;박승호;남상륜
    • Radiation Oncology Journal
    • /
    • 제11권2호
    • /
    • pp.397-401
    • /
    • 1993
  • 자궁경부암 환자의 병변의 범위 및 임상 경과를 추정하는데 TA-4의 유용성을 검토하고자 충남대학교병원에서 자궁경부암으로 진단 받은 58명의 환자를 대상으로 혈청 TA-4치를 RIA 방법으로 측정하여 $\le2\;ng/ml$을 정상 범위로 정하여 다음과 같은 결과를 얻었다. 1) 치료전 평평상피암 환자의 TA-4의 양성율은 $60\%,$ 선암은 $40\%$였다. 2) 병기가 진행될수록TA-4의 양성율및 평균치가 높아서, 양성율 병기 I는 $40\%,$ II는 $72\%,$ III는 $63\%,$ IV는 $100\%$였으며 평균치는 병기 I에서 3.1, II는 6.6, III는 8, IV는17.7 ng/ml였다. 3) 방사선 치료후 혈청내 TA-4치는 감소하여 5000 cGy 조사후 치료전 양성을 보였던 환자의 $44\%$에서 TA-4치 가 정상으로 돌아왔다. 4) 원발성 자궁경부암 환자의 양성율은 $59\%$였으나 지속성 또는 재발성등 치료에 실패한 15명 환자의 양성율은 $80\%$였다. 이상으로 연속적 혈청내 TA-4치의 측정은 자궁경부암 환자의 방사선치료에 따른 임상 경과를 관찰하는데 도움이 될 것으로 사료된다.

  • PDF

국소 재발된 유방암의 방사선치료 (Radiotherapy in Locoregional Recurrent Breast Carcinoma)

  • 하성환;양미경;정웅기;박찬일;방영주;김노경;최국진
    • Radiation Oncology Journal
    • /
    • 제6권2호
    • /
    • pp.203-209
    • /
    • 1988
  • 국소적으로 재발된 유방암의 경우, 근래에 와서 치료법의 발다로 관해율도 증가되고, 또한 환자의 수명도 연장시킬 수 있다는 보고가 증가되고 아울러 관심도 높아지고 있는 상태이다. 따라서 이런 국소 재발된 유방암을 가진 환자의 특성과 치료에 대한 실패양상, 그리고 예후에 영향을 미치는 인자들을 분석하여 이들 환자에 대한 치료에 도움이 되고자, 서울대학교 병원에서는 1979년에서 1986년까지 치료받은 총 33예에 대해서 분석을 하여 다음과 같은 결과를 얻었다. 15예(45%)에서 흉벽에 국한되어 재발하였고, 18예가 임파절에 재발을 하였다. 초기 치료후 36개월만에 87%가 재발을 보였다. 원전절제를 받아 방사선치료에 대한 판정을 할 수 없었던 8예를 제외한 25예에서 72%(18예)가 방사선치료 후 완전관해를 보였다. 국소재발 후 3년 동안의 생존율은 50%였다. 초기 치료후 2년이내 재발한 환자들의 3년 생존율은 24%였고, 2년 이후 재발한 경우는 100%였다. 흉벽에만 재발한 경우, 3년 생존율은 57%였고, 임파절에만 재발한 경우는 43%였다. 후자의 경우 대부분이 원격전이를 보였다. 완전관해를 보인 예와, 그렇지 않은 예에서는 각각 63%의 3년 생존율, 그리고 33%의 1년 생존율을 보였다. 3명의 환자가 대측 유방에 암을 보였다. 원발성 유방암에 대해서 수술과 전신치료를 함께 받은 경우 3년 생존율이 40%였고, 수술만 시행한 경우는 71%였다. 방사선 치료후 후속적 재발을 보인 경우의 2년 생존율은 25%였다.

  • PDF

진행성 위암 환자예시의 FOLFOX 6 항암치료 (Modified FOLFOX-6 Chemotherapy for Recurrent or Inoperable Gastric Cancer Patients)

  • 지성배;한재현;허훈;송교영;진형민;김욱;박조현;박승만;김승남;전해명
    • Journal of Gastric Cancer
    • /
    • 제8권1호
    • /
    • pp.40-46
    • /
    • 2008
  • 목적: 재발했거나 수술이 불가능한 진행성 위암 환자에 있어서 FOIFOX 항암치료의 반응성 및 독성에 대한 초기경험을 조사, 정리하고자 하였다. 대상 및 방법: 2006년 4월부터 2007년 8월까지 근치적 위암 절제술 후 재발한 환자 35명과 수술 불가능한 위암으로 처음 진단된 환자 43명을 대상으로 modified FOIFOX-6 항암 치료를 진행하였으며, 그 결과를 후향적으로 분석하였다. 결과: 총 78명의 환자를 대상으로 평균 7.1회의 항암치료를 시행하였으며 RECIST 기준에 의한 부분 관해가 11명(14.1%)의 환자에서 관찰되었으며 안정 상태는 35명(44.9%)이었고 진행성 병변은 32명(44%)이었다. 진행성 병변이 나타나는데 걸리는 시간의 중앙값은 6개월이었으며 생존기간의 평균값은 13개월이었다. 독성 평가에서 1, 2등급의 빈혈이 가장 많은 41명의 환자에서 나타났으며 1, 2등급의 혈소판 감소증은 14명의 환자에서 나타났고 20명의 환자에서 1, 2등급의 말초신경독성을 보였다. 13명의 환자에서 진행성 병변에 의해 FOIFOX에서 S1-cisplatin으로 항암제의 교체가 있었으나 평균 1.76회 밖에 진행할 수 없었다. 결론: 59%의 환자에서 안정 상태 이상의 반응을 보였으며 어떠한 3, 4등급의 독성반응도 관찰되지 않았으므로, 수술 불가능하거나 재발한 위암 환자에서 FOLFOX 항암치료는 비교적 무난한 독성과 유리한 생존을 보이는 적절한 1차적 약제 선택으로 생각된다.

  • PDF

다발성 원발성 폐암 수술치험 1례 (Multiple Primary Lung Cancer; A Case Report)

  • 윤용한;이두연;이기범
    • Journal of Chest Surgery
    • /
    • 제26권9호
    • /
    • pp.722-725
    • /
    • 1993
  • Multiple primary lung cancer is a rare disease entity and its clinical characteristics, treatment, and prognosis are poorly described. But the multiple primary lung cancer have a more favorable prognosis than locally recurrent or metastastic disease. Therefore, appropriate identification of multiple primary lung cancer will be very important. We have experienced a case of stage I multiple primary lung cancer in a 76-year-old male with two large mass in the right lower lobe without metastasis in the mediastinal lymph nodes with right mid and lower lobectomy. The microscopic pictures revealed adenocarcinoma in the one & small cell carcinoma in another. The post-operative courses were in uneventful for 4 months & but he was treated with chemotherapies, 2 times for complete remission of small cell carcinoma to now after discharge.

  • PDF

Polytetrafluoroethylene 인조혈관을 이용한 동맥재건술: 3례 보 (Three cases report of arterial bypass graft using polytetrafluoroethylene vascular prosthesis)

  • 이철세
    • Journal of Chest Surgery
    • /
    • 제17권4호
    • /
    • pp.691-697
    • /
    • 1984
  • After the real birth of vascular surgery occurred with the introduction of the first practical arterial prosthesis about 50 years ago, a variety of potential vascular graft had been tested and rejected. Polytetrafluoroethylene [Teflon, PTFE] was first used as a vascular prosthesis in 1957. Thereafter this pros-thesis was first used clinically in 1972 and has subsequently been widely applied as a small and medium sized vessel replacement because it is easy to use and readily available. There are numerous reports of good results about Polytetrafluoroethylene graft. We experienced the three cases of arterial bypass graft using polytetrafluoroethylene vascular pros-thesis. First, 21 years old female patient had suffered from Takayasus disease which affected the left subclavian artery and right subclavian-left axillary extra anatomical bypass graft as done. Second, 64 years old male patient had suffered from Leriche syndrome for 12 years and the left axillofemoral and femorofemoral extra anatomical bypass graft was done. Third, 34 years old male patient had suffered from recurrent Buergers disease which affected the left popliteal artery and the isolated popliteal artery segment bypass graft was done. Relatively satisfactory result was obtained in early post-operative period in all three cases.

  • PDF